Chimerix Inc. (NASDAQ:CMRX) finished Friday with a subtraction of -$0.03 to close at $0.98, a downside of -3.22 percent. An average of 915,500 shares of common stock have been traded in the last five days. There was a fall of -$0.1200 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 754,590 shares traded, while the 50-day average volume stands at 1,064,564.
CMRX stock has decreased by -19.21% in the last month. The company shares reached their 1-month lowest point of $0.9700 on 08/11/23. With the stock rallying to its 52-week high on 01/13/23, shares of the company touched a low of $1.00 and a high of $2.78 in 52 weeks. It has reached a new high 6 times so far this year and lost -47.45% or -$0.8800 in price. In spite of this, the price is down -64.84% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CMRX stock investors should be aware that Chimerix Inc. (CMRX) stock had its last reported insider trading activity 198 days ago on May 18. In this transaction, the insider spent $5,686. Principal Accounting Officer, Jakeman David, disposed of 4,400 shares at a price of $1.86 on Sep 29. The insider now owns more than $8,185 worth of shares.
Valuation Metrics
Chimerix Inc. (CMRX) has a trailing price-to-earnings (P/E) ratio of 0.49. The stock’s beta is 1.13. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.68, the price-to-book (PB) ratio at 0.39.
Financial Health
Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Chimerix Inc.’s EBITDA margin for the year ending June 29 is -178.21%. Its gross profit as reported stood at $33.38 million compared to revenue of $33.82 million.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$18.58 million in the quarter, while revenues of -$21.37 million were shrunk -26.32%. The analyst consensus anticipated Chimerix Inc.’s latest quarter earnings to come in at -$0.24 per share, but it turned out to be -$0.21, a 12.50% surprise. For the quarter, EBITDA amounted to -$23.16 million. Shareholders own equity worth $88.58 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Chimerix Inc. (CMRX) price momentum. RSI 9-day as of the close on 11 August was 17.02%, suggesting the stock is oversold, with historical volatility in this time frame at 25.17%.
As of today, CMRX’s price is $1.0260 -10.91% or -$0.1200 from its 5-day moving average. CMRX is currently trading -17.65% lower than its 20-day SMA and -23.44% lower than its 100-day SMA. However, the stock’s current price level is -28.99% below the SMA50 and -41.32% below the SMA200.
The stochastic %K and %D were 4.49% and 7.74%, respectively, and the average true range (ATR) was 0.0537. With the 14-day stochastic at 4.17% and the average true range at 0.0546, the RSI (14) stands at 24.39%. The stock has reached -0.0811 on the 9-day MACD Oscillator while the 14-day reading was at -0.1081.
Analyst Ratings
Robert W. Baird launched coverage on Chimerix Inc. (NASDAQ: CMRX) in its analyst report released on May 23, 2023. The firm assigned the stock an Outperform rating. The consensus rating for Chimerix Inc. (CMRX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CMRX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 5 others rate it as a “buy”.
What is CMRX’s price target for the next 12 months?
Analysts predict a range of price targets between $5.00 and $11.00, with a median target of $7.00. Taking a look at these predictions, the average price target given by analysts for Chimerix Inc. (CMRX) stock is $7.00.
